Pilot Study Evaluating the Elasticity and Shear Wave Modulus (Stiffness) of the Median Nerve in Patients With Mild to Moderate Idiopathic Carpal Tunnel Syndrome Receiving OMT and Conservative Therapy
Launched by KETTERING HEALTH NETWORK · Nov 20, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how flexible and stiff the median nerve becomes in patients with mild to moderate carpal tunnel syndrome after they receive a specific type of therapy called osteopathic manipulative therapy (OMT) along with standard care. Carpal tunnel syndrome can cause pain, numbness, and weakness in the hand due to pressure on the median nerve, which runs through the wrist. Researchers want to see if OMT can help improve the condition by measuring changes in the nerve's elasticity and stiffness.
To participate in the trial, individuals must have a diagnosis of mild to moderate carpal tunnel syndrome, confirmed by recent tests. However, people with certain conditions, such as severe carpal tunnel syndrome, recent wrist injuries or surgeries, or certain systemic diseases (like diabetes or thyroid disorders), are not eligible. Participants in the study will likely undergo assessments to measure the stiffness of their median nerve and receive OMT treatment. This trial is currently looking for volunteers of all genders between the ages of 18 and 74 who meet the eligibility criteria. If you're considering joining, it’s a great opportunity to contribute to understanding potential treatments for carpal tunnel syndrome.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of unilateral or bilateral mild to moderate carpal tunnel syndrome, based on recent EMG findings
- Exclusion Criteria:
- • History of undergoing recent physical therapy for treatment of carpal tunnel syndrome
- • History of wrist trauma or surgery
- • Hypothyroidism
- • Severe CTS that has progressed to muscle atrophy
- • Systemic disease or condition including but not limited to diabetes mellitus, thyroid disorders, rheumatoid disorders, Paget's bone disease, gout, myxedema, multiple myeloma, acromegaly, hepatic disease, dialysis patients, or other diseases or conditions in which peripheral neuropathies are common.
- • Secondary cause of CTS such as a ganglion cyst, mass, or an accessory muscle shown by US or MRI of the affected wrist.
- • Bifid median nerve as shown by US or MRI of the affected wrist
- • pregnant or recently postpartum
About Kettering Health Network
Kettering Health Network is a comprehensive healthcare system dedicated to enhancing the health and well-being of the communities it serves through innovative clinical research and patient-centered care. With a commitment to advancing medical knowledge and improving treatment outcomes, Kettering Health Network engages in a wide range of clinical trials across various therapeutic areas. The organization combines state-of-the-art facilities, a multidisciplinary team of experienced professionals, and a patient-centric approach to ensure the highest standards of safety and efficacy in its research endeavors. By fostering collaboration between researchers, healthcare providers, and patients, Kettering Health Network aims to translate cutting-edge research into meaningful healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dayton, Ohio, United States
Patients applied
Trial Officials
Roland Gazaille, DO
Principal Investigator
Kettering Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported